A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity

Immunotherapy with chimeric antigen receptor T (CAR-T cells) has been recently approved for patients with relapsed/refractory B-lymphoproliferative neoplasms. Along with great efficacy in patients with poor prognosis, CAR-T cells have been also linked with novel toxicities in a significant portion o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavriilaki, Eleni, Sakellari, Ioanna, Gavriilaki, Maria, Anagnostopoulos, Achilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312228/
https://www.ncbi.nlm.nih.gov/pubmed/32485958
http://dx.doi.org/10.3390/ijms21113886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312228/
https://www.ncbi.nlm.nih.gov/pubmed/32485958
http://dx.doi.org/10.3390/ijms21113886

Ejemplares similares